Proteases for Pharmaceutical Use
AssigneesNovozymes A/S, Solvay Pharmaceuticals GmbH
InventorsAllan Svendsen, Claus Crone Fuglsang, Peter Colin Gregory
Life of this patent
Estimating the term…
Abstract
The pharmaceutical use of proteases related to amino acids 1-274 of SEQ ID NO: 2, the serine protease derived from Bacillus licheniformis, which is also designated subtilisin Carlsberg, optionally in combination with a lipase and/or an amylase. Examples of medical indications are: Treatment of digestive disorders, pancreatic exocrine insufficiency (PEI), pancreatitis, cystic fibrosis, diabetes type I, and/or diabetes type II.
Claims18
An isolated protease having at least 50% identity to amino acids 1-274 of SEQ ID NO:
- 2, for use as a medicament.
A method for the treatment of digestive disorders, pancreatic exocrine insufficiency, pancreatitis, cystic fibrosis, diabetes type I, and/or diabetes type II, comprising administering a therapeutically effective amount of a protease of claim 20.
Dependencies are inferred from the claim text.